Filing Flows › Comparisons › AQST vs WHWK
Aquestive Therapeutics vs Whitehawk Therapeutics: AQST and WHWK compared
Aquestive Therapeutics is the larger company: $7.6M of revenue in its latest quarter (Q3 2026) against $7.1M for Whitehawk Therapeutics (Q1 2025). Whitehawk Therapeutics is growing faster (+34% against -41% a year earlier). Aquestive Therapeutics is more profitable, with an operating margin of -191.5% against -213.0%.
Where the money goes: AQST and WHWK
Aquestive Therapeutics (AQST) · Q3 2026
Aquestive Therapeutics, Q3 2026: revenue $7.6M (-41% year over year), operating margin -191.5%, net loss $16.5M, operating cash flow −$7.0M. The chart follows the revenue to costs, profit and cash.
Whitehawk Therapeutics (WHWK) · Q1 2025
Whitehawk Therapeutics, Q1 2025: revenue $7.1M (+34% year over year), operating margin -213.0%, net earnings $73.0M, operating cash flow −$11.9M. The chart follows the revenue to costs, profit and cash.
| Aquestive Therapeutics (AQST) | Whitehawk Therapeutics (WHWK) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q1 2025 |
| Revenue | $7.6M | $7.1M |
| Revenue growth, Y/Y | -41% | +34% |
| Operating margin | -191.5% | -213.0% |
| Net earnings | −$16.5M | $73.0M |
| Net margin | -218.3% | — |
| Operating cash flow | −$7.0M | −$11.9M |
Where the revenue comes from
Aquestive Therapeutics
- Manufacture and supply revenue: $6.7M (88%)
- License and Royalty Revenue: $824K (11%)
- Co-development and research fees: $74K (1%)
Questions
Which is bigger, Aquestive Therapeutics or Whitehawk Therapeutics?
Aquestive Therapeutics is the larger company: $7.6M of revenue in its latest quarter (Q3 2026) against $7.1M for Whitehawk Therapeutics (Q1 2025).
Is Aquestive Therapeutics or Whitehawk Therapeutics growing faster?
Whitehawk Therapeutics is growing faster (+34% against -41% a year earlier).
Which is more profitable, Aquestive Therapeutics or Whitehawk Therapeutics?
Aquestive Therapeutics is more profitable, with an operating margin of -191.5% against -213.0%.
More: Aquestive Therapeutics earnings · how Aquestive Therapeutics makes money · Whitehawk Therapeutics earnings · how Whitehawk Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed May 8, 2025). Fiscal quarters can end on different dates. Not investment advice.